Dimensional Fund Advisors’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-34,607
Closed -$133K 3526
2023
Q2
$133K Hold
34,607
﹤0.01% 3292
2023
Q1
$105K Buy
+34,607
New +$120K ﹤0.01% 3295
2022
Q3
$143K Buy
+41,341
New +$188K ﹤0.01% 3290

Other funds holding DBTX

Dimensional Fund Advisors's DBTX Position: Q3 2023 in Review

Dimensional Fund Advisors sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 34,607 shares — an estimated $133K sold.

Dimensional Fund Advisors first reported a position in DBTX in Q3 2022 and held it in 3 quarters. The position peaked at $143K in Q3 2022. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

  • Dimensional Fund Advisors reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 34,607 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $133K.
  • Dimensional Fund Advisors first reported a position in Decibel Therapeutics, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
  • Dimensional Fund Advisors's Decibel Therapeutics, Inc. Common Stock position peaked at $143K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Dimensional Fund Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.